Zurcher Kantonalbank Zurich Cantonalbank Boosts Stock Position in Keurig Dr Pepper Inc. (NASDAQ:KDP)

Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP) by 284.7% in the fourth quarter, Holdings Channel.com reports. The fund owned 786,925 shares of the company’s stock after acquiring an additional 582,382 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Keurig Dr Pepper were worth $26,220,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the business. OFI Invest Asset Management bought a new stake in Keurig Dr Pepper during the 3rd quarter valued at $25,000. Geneos Wealth Management Inc. raised its position in Keurig Dr Pepper by 973.8% during the 3rd quarter. Geneos Wealth Management Inc. now owns 902 shares of the company’s stock valued at $28,000 after purchasing an additional 818 shares in the last quarter. Turtle Creek Wealth Advisors LLC bought a new stake in Keurig Dr Pepper during the 4th quarter valued at $29,000. Bruce G. Allen Investments LLC bought a new stake in Keurig Dr Pepper during the 4th quarter valued at $34,000. Finally, Resurgent Financial Advisors LLC bought a new stake in Keurig Dr Pepper during the 4th quarter valued at $34,000. Hedge funds and other institutional investors own 85.23% of the company’s stock.

Keurig Dr Pepper Trading Up 1.4 %

KDP opened at $30.88 on Thursday. The stock has a fifty day moving average price of $30.25 and a 200-day moving average price of $31.00. Keurig Dr Pepper Inc. has a 12 month low of $27.66 and a 12 month high of $35.99. The firm has a market cap of $42.85 billion, a price-to-earnings ratio of 19.92, a PEG ratio of 2.32 and a beta of 0.66. The company has a current ratio of 0.38, a quick ratio of 0.25 and a debt-to-equity ratio of 0.39.

Keurig Dr Pepper (NASDAQ:KDP) last announced its earnings results on Thursday, February 22nd. The company reported $0.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.01. Keurig Dr Pepper had a return on equity of 9.93% and a net margin of 14.72%. The company had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.92 billion. During the same period in the prior year, the company posted $0.50 EPS. The firm’s quarterly revenue was up 1.7% compared to the same quarter last year. As a group, equities research analysts anticipate that Keurig Dr Pepper Inc. will post 1.91 earnings per share for the current fiscal year.

Keurig Dr Pepper Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a dividend of $0.215 per share. This represents a $0.86 annualized dividend and a yield of 2.78%. The ex-dividend date was Wednesday, March 27th. Keurig Dr Pepper’s dividend payout ratio is currently 55.48%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Royal Bank of Canada decreased their target price on Keurig Dr Pepper from $42.00 to $41.00 and set an “outperform” rating for the company in a research report on Friday, February 23rd. Wedbush decreased their target price on Keurig Dr Pepper from $37.00 to $35.00 and set an “outperform” rating for the company in a research report on Monday, February 26th. Morgan Stanley decreased their target price on Keurig Dr Pepper from $37.00 to $34.00 and set an “equal weight” rating for the company in a research report on Monday, February 26th. HSBC began coverage on Keurig Dr Pepper in a research report on Friday, December 22nd. They issued a “hold” rating and a $37.00 price target for the company. Finally, Barclays boosted their price target on Keurig Dr Pepper from $32.00 to $36.00 and gave the stock an “overweight” rating in a research report on Friday, April 12th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $36.45.

Insider Activity at Keurig Dr Pepper

In related news, major shareholder Holdings B.V. Jab sold 51,956,522 shares of the company’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $28.90, for a total transaction of $1,501,543,485.80. Following the transaction, the insider now directly owns 331,487,357 shares of the company’s stock, valued at approximately $9,579,984,617.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, CEO Robert James Gamgort purchased 171,821 shares of the company’s stock in a transaction on Tuesday, March 5th. The shares were acquired at an average price of $29.10 per share, for a total transaction of $4,999,991.10. Following the purchase, the chief executive officer now owns 3,179,917 shares in the company, valued at $92,535,584.70. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder Holdings B.V. Jab sold 51,956,522 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $28.90, for a total value of $1,501,543,485.80. Following the sale, the insider now owns 331,487,357 shares in the company, valued at approximately $9,579,984,617.30. The disclosure for this sale can be found here. Insiders have sold 100,012,132 shares of company stock valued at $2,890,354,861 in the last ninety days. Corporate insiders own 0.81% of the company’s stock.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.